Technical Analysis for INZY - Inozyme Pharma, Inc.

Grade Last Price % Change Price Change
grade D 23.8 1.10% 0.26
INZY closed up 1.1 percent on Friday, October 23, 2020, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical INZY trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
20 DMA Support Bullish 2.45%
Narrow Range Bar Range Contraction 2.45%
Inside Day Range Contraction 2.45%
20 DMA Support Bullish 2.45%
Up 3 Days in a Row Strength 0.98%
Up 4 Days in a Row Strength 0.98%
Older End-of-Day Gignals for INZY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 2 days ago
Rose Above Previous Day's High 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Rare Genetic Diseases Recombinant Dna Yale University

Is INZY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.6499
52 Week Low 16.1
Average Volume 86,629
200-Day Moving Average 0.00
50-Day Moving Average 24.93
20-Day Moving Average 22.84
10-Day Moving Average 23.04
Average True Range 2.02
ADX 16.54
+DI 18.49
-DI 14.54
Chandelier Exit (Long, 3 ATRs ) 20.35
Chandelier Exit (Short, 3 ATRs ) 25.63
Upper Bollinger Band 25.89
Lower Bollinger Band 19.79
Percent B (%b) 0.66
BandWidth 26.70
MACD Line -0.11
MACD Signal Line -0.37
MACD Histogram 0.255
Fundamentals Value
Market Cap 556.08 Million
Num Shares 23.4 Million
EPS -1.11
Price-to-Earnings (P/E) Ratio -21.50
Price-to-Sales 0.00
Price-to-Book 9.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.15
Resistance 3 (R3) 25.23 24.86 24.93
Resistance 2 (R2) 24.86 24.52 24.82 24.85
Resistance 1 (R1) 24.33 24.30 24.60 24.25 24.77
Pivot Point 23.96 23.96 24.09 23.92 23.96
Support 1 (S1) 23.43 23.62 23.70 23.35 22.83
Support 2 (S2) 23.06 23.40 23.02 22.75
Support 3 (S3) 22.53 23.06 22.68
Support 4 (S4) 22.45